var data={"name":"Primary and secondary immunodeficiency states (non HIV)","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Antibody deficiencies","type":"SUBSECTION","items":[{"name":"Agammaglobulinemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=agammaglobulinemia"},{"name":"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-epidemiology-and-diagnosis-of-common-variable-immunodeficiency-in-adults"},{"name":"Common variable immunodeficiency in children","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=common-variable-immunodeficiency-in-children"},{"name":"Gastrointestinal manifestations in primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gastrointestinal-manifestations-in-primary-immunodeficiency"},{"name":"Hyperimmunoglobulin M syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hyperimmunoglobulin-m-syndromes"},{"name":"IgG subclass deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=igg-subclass-deficiency"},{"name":"IgG subclasses: Physical properties, genetics, and biologic functions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=igg-subclasses-physical-properties-genetics-and-biologic-functions"},{"name":"Intravenous immune globulin: Adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intravenous-immune-globulin-adverse-effects"},{"name":"Malignancy in primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=malignancy-in-primary-immunodeficiency"},{"name":"Pathogenesis of common variable immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-common-variable-immunodeficiency"},{"name":"Primary humoral immunodeficiencies: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-humoral-immunodeficiencies-an-overview"},{"name":"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-iga-deficiency-clinical-manifestations-pathophysiology-and-diagnosis"},{"name":"Selective IgA deficiency: Management and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-iga-deficiency-management-and-prognosis"},{"name":"Selective IgE deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-ige-deficiency"},{"name":"Selective IgM deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-igm-deficiency"},{"name":"Specific antibody deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=specific-antibody-deficiency"},{"name":"Treatment and prognosis of common variable immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-common-variable-immunodeficiency"}]},{"name":"Chromosomal breakage syndromes associated with immunodeficiency","type":"SUBSECTION","items":[{"name":"Ataxia-telangiectasia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ataxia-telangiectasia"},{"name":"Bloom syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bloom-syndrome"},{"name":"Nijmegen breakage syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nijmegen-breakage-syndrome"}]},{"name":"Combined immunodeficiency","type":"SUBSECTION","items":[{"name":"Adenosine deaminase deficiency: Pathogenesis, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adenosine-deaminase-deficiency-pathogenesis-clinical-manifestations-and-diagnosis"},{"name":"Adenosine deaminase deficiency: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adenosine-deaminase-deficiency-treatment"},{"name":"CD3/T cell receptor complex disorders causing immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cd3-t-cell-receptor-complex-disorders-causing-immunodeficiency"},{"name":"Combined immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=combined-immunodeficiencies"},{"name":"Newborn screening for primary immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=newborn-screening-for-primary-immunodeficiencies"},{"name":"Purine nucleoside phosphorylase deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=purine-nucleoside-phosphorylase-deficiency"},{"name":"Severe combined immunodeficiency (SCID) with JAK3 deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=severe-combined-immunodeficiency-scid-with-jak3-deficiency"},{"name":"Severe combined immunodeficiency (SCID): An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=severe-combined-immunodeficiency-scid-an-overview"},{"name":"Severe combined immunodeficiency (SCID): Specific defects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=severe-combined-immunodeficiency-scid-specific-defects"},{"name":"T cell receptor signaling","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-cell-receptor-signaling"},{"name":"T-B-NK+ SCID: Clinical manifestations, diagnosis, and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-b-nk-scid-clinical-manifestations-diagnosis-and-treatment"},{"name":"T-B-NK+ SCID: Pathogenesis and genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-b-nk-scid-pathogenesis-and-genetics"},{"name":"X-linked severe combined immunodeficiency (SCID)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=x-linked-severe-combined-immunodeficiency-scid"},{"name":"ZAP-70 deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=zap-70-deficiency"}]},{"name":"Immunodeficiency disorders - General considerations","type":"SUBSECTION","items":[{"name":"Approach to the adult with recurrent infections","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-adult-with-recurrent-infections"},{"name":"Approach to the child with recurrent infections","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-child-with-recurrent-infections"},{"name":"Assessing the immunologic response to vaccination","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=assessing-the-immunologic-response-to-vaccination"},{"name":"Autoimmunity in patients with primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autoimmunity-in-patients-with-primary-immunodeficiency"},{"name":"Flow cytometry for the diagnosis of primary immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=flow-cytometry-for-the-diagnosis-of-primary-immunodeficiencies"},{"name":"Gene therapy for primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gene-therapy-for-primary-immunodeficiency"},{"name":"Hematopoietic cell transplantation for primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematopoietic-cell-transplantation-for-primary-immunodeficiency"},{"name":"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immune-and-microbial-mechanisms-in-the-pathogenesis-of-inflammatory-bowel-disease"},{"name":"Immune function in older adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immune-function-in-older-adults"},{"name":"Immune globulin therapy in primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immune-globulin-therapy-in-primary-immunodeficiency"},{"name":"Immunizations in patients with primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunizations-in-patients-with-primary-immunodeficiency"},{"name":"Laboratory evaluation of the immune system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=laboratory-evaluation-of-the-immune-system"},{"name":"Primary immunodeficiency: Overview of management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-immunodeficiency-overview-of-management"},{"name":"Recognition of immunodeficiency in the newborn period","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=recognition-of-immunodeficiency-in-the-newborn-period"},{"name":"Subcutaneous and intramuscular immune globulin therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=subcutaneous-and-intramuscular-immune-globulin-therapy"}]},{"name":"Other","type":"SUBSECTION","items":[{"name":"Pulmonary complications of primary immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pulmonary-complications-of-primary-immunodeficiencies"},{"name":"Syndromic immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=syndromic-immunodeficiencies"}]},{"name":"Other well defined immunodeficiency syndromes","type":"SUBSECTION","items":[{"name":"Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-clinical-features-and-diagnosis"},{"name":"Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-epidemiology-and-pathogenesis"},{"name":"Autoimmune lymphoproliferative syndrome (ALPS): Management and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-management-and-prognosis"},{"name":"Autosomal dominant hyperimmunoglobulin E syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autosomal-dominant-hyperimmunoglobulin-e-syndrome"},{"name":"Cartilage-hair hypoplasia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cartilage-hair-hypoplasia"},{"name":"Chronic mucocutaneous candidiasis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-mucocutaneous-candidiasis"},{"name":"DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=digeorge-22q11-2-deletion-syndrome-clinical-features-and-diagnosis"},{"name":"DiGeorge (22q11.2 deletion) syndrome: Epidemiology and pathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=digeorge-22q11-2-deletion-syndrome-epidemiology-and-pathogenesis"},{"name":"DiGeorge (22q11.2 deletion) syndrome: Management and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=digeorge-22q11-2-deletion-syndrome-management-and-prognosis"},{"name":"IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ipex-immune-dysregulation-polyendocrinopathy-enteropathy-x-linked"},{"name":"Idiopathic CD4+ lymphocytopenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=idiopathic-cd4-lymphocytopenia"},{"name":"Idiopathic systemic capillary leak syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=idiopathic-systemic-capillary-leak-syndrome"},{"name":"Mannose-binding lectin","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mannose-binding-lectin"},{"name":"Mannose-binding lectin deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mannose-binding-lectin-deficiency"},{"name":"Mendelian susceptibility to mycobacterial diseases: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mendelian-susceptibility-to-mycobacterial-diseases-an-overview"},{"name":"Mendelian susceptibility to mycobacterial diseases: Specific defects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mendelian-susceptibility-to-mycobacterial-diseases-specific-defects"},{"name":"NK cell deficiency syndromes: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nk-cell-deficiency-syndromes-clinical-manifestations-and-diagnosis"},{"name":"NK cell deficiency syndromes: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nk-cell-deficiency-syndromes-treatment"},{"name":"Wiskott-Aldrich syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=wiskott-aldrich-syndrome"},{"name":"X-linked lymphoproliferative disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=x-linked-lymphoproliferative-disease"}]},{"name":"Phagocyte disorders","type":"SUBSECTION","items":[{"name":"Acquired deficiencies of the complement system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-deficiencies-of-the-complement-system"},{"name":"Approach to the adult with unexplained neutropenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-adult-with-unexplained-neutropenia"},{"name":"Chediak-Higashi syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chediak-higashi-syndrome"},{"name":"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-granulomatous-disease-pathogenesis-clinical-manifestations-and-diagnosis"},{"name":"Chronic granulomatous disease: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-granulomatous-disease-treatment-and-prognosis"},{"name":"Congenital neutropenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=congenital-neutropenia"},{"name":"Cyclic neutropenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cyclic-neutropenia"},{"name":"Immune neutropenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immune-neutropenia"},{"name":"Inherited disorders of the complement system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inherited-disorders-of-the-complement-system"},{"name":"Leukocyte-adhesion deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=leukocyte-adhesion-deficiency"},{"name":"Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=myeloperoxidase-deficiency-and-other-enzymatic-wbc-defects-causing-immunodeficiency"},{"name":"Neutrophil-specific granule deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neutrophil-specific-granule-deficiency"},{"name":"Overview and clinical assessment of the complement system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-and-clinical-assessment-of-the-complement-system"},{"name":"Overview of neutropenia in children and adolescents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-neutropenia-in-children-and-adolescents"},{"name":"Primary disorders of phagocytic function: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-disorders-of-phagocytic-function-an-overview"}]},{"name":"Secondary immunodeficiency","type":"SUBSECTION","items":[{"name":"Safety of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=safety-of-antiinflammatory-and-immunosuppressive-drugs-in-rheumatic-diseases-during-pregnancy-and-lactation"},{"name":"Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=secondary-immunodeficiency-due-to-underlying-disease-states-environmental-exposures-and-miscellaneous-causes"},{"name":"Secondary immunodeficiency induced by biologic therapies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=secondary-immunodeficiency-induced-by-biologic-therapies"}]}]}